New study explores surgery hope for inoperable pancreatic cancer
NCT ID NCT07241663
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at patients with locally advanced pancreatic cancer that cannot be removed by surgery at first. After at least 4 months of chemotherapy, if the tumor shrinks enough, doctors may consider surgery. The goal is to see if this approach helps patients live longer and maintain a better quality of life. About 150 adults from expert centers around the world will take part.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LOCALLY ADVANCED PANCREATIC ADENOCARCINOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
UOC Chirurgia Generale 2, Azienda Ospedale di Padova, Padova, Italy 35128
RECRUITINGPadova, Italy
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Four-Drug cocktail aims to shrink pancreatic tumors before surgery
- Immune cells armed with antibody take on pancreatic cancer
- New drug AB801 aims to boost chemo and immunotherapy in tough cancers
- New PET tracer could light up pancreatic tumors
- New drug combo aims to tackle pancreatic cancer in patients with inherited gene mutations
- Blasting pancreatic tumors with extra radiation may open door to surgery